Month: February 2022

Categories
Pharmaceutical

Sales Of Carbapenem-Based Antibiotics Market Is Estimated To Reach A Valuation Of US$1.8 Bn By 2029

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the Carbapenem-based Antibiotics  Market during the historical period. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2019, and key prospects over the forecast period. The insights and analytics on the  Carbapenem-based Antibiotics  Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment, end-use/application prospects analysis, and competitive landscape assessment.

Sample Report   https://www.factmr.com/connectus/sample?flag=S&rep_id=4425

The following insights and evaluations are worth knowing for any market participant, helping them in ascertaining the prevailing dynamics and the future trajectories of the Carbapenem-based Antibiotics    Market. They are a part of the estimations of the opportunities in various segments. The additional new opportunities have turned the Carbapenem-based Antibiotics    Market into a fragmented landscape with more entry-level players entering the market, thanks to low barriers for investments. The research report published by Fact.MR on the Carbapenem-based Antibiotics   Market provides a detailed overview of the demands and consumptions of various products/services associated with the growth dynamics of the market during the forecast period.

The in-depth market estimation of various opportunities in the segments is expressed in volumes and revenues. The insights and analytics on the Carbapenem-based Antibiotics    market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment, end-use/application prospects analysis, and competitive landscape assessment.

Buy Now  https://www.factmr.com/checkout/4425

After reading the Carbapenem-based Antibiotics    Market report, readers get insight into: 

  • Major drivers and restraining factors, opportunities and challenges, and the competitive landscape
  • New, promising avenues in key regions
  • New revenue streams for all players in emerging markets
  • Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions
  • Demand and uptake patterns in key industries of the Carbapenem-based Antibiotics    Market
  • New research and development projects in new technologies in key regional markets
  • Changing revenue share and size of key product segments during the forecast period
  • Technologies and business models with disruptive potential 

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The Carbapenem-based Antibiotics    Market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period. In coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study.

Some important questions that the Carbapenem-based Antibiotics    Market report tries to answer exhaustively are: 

  • Key strategic moves by various players in the Carbapenem-based Antibiotics    Market in recent years with respect to product launches, deals and tie-ups, and mergers and acquisitions, and divestment of shares
  • Which strategies will enable top players in the Carbapenem-based Antibiotics    Market to expand their geographic footprint
  • Which new business models are expected to change the course of growth of key regional markets in near future
  • Which technologies will witness most attractive research investments and what will be the key sources of funding for startups and new entrants
  • Which products segments have in recent years have seen new, lucrative application areas

 Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=4425

Benefits of Fact.MR Study

Fact.MR has gradually established itself as one of the leading market research companies across the globe. Our unique, methodical, and up-to-date approach towards creating high-quality market reports ensures the reports include relevant market insights. Further, our team of analysts leaves no stone unturned while curating market reports in accord with the requirement of our clients.  

Why Choose Fact.MR?

  1. Deliver updated information on the current industry trends
  2. Available 24/7 to facilitate clients with unbiased solutions
  3. Embrace digital technologies to offer accurate business ideas
  4. Exhaustive supply chain augmentation analysis
  5. Provide reports strictly according to the requirements of the clients

For More Insights- https://www.newswire.co.kr/newsRead.php?no=923711

 About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner.

 Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Demand For Dental 3d Printing Market Would Witness A Whopping 2.6x Growth Over The Forecast Period 2022-2032

Selective laser sintering technology would surpass the adoption rate of vat photopolymerisation technology, as time-efficiency and accuracy are turning into viable features of dental 3D printers. However, value-added features come at a cost-albeit a high one-which could adversely impact the sales of dental 3D printers.

To offset this barrier, public and private initiatives are being taken in North America and Europe, through the introduction of favourable reimbursement plans, which are projected to drive the attention of the masses towards dental care. This, in turn, would encourage dental professionals to adopt advanced 3D printers, given the availability of long-term payback opportunities. A recent study by Fact.MR shows that, the dental 3D printing market is set to witness an impressive CAGR of 15% during the forecast period (2020-2027).

 Request  Sample  https://www.factmr.com/connectus/sample?flag=S&rep_id=4361

Key Highlights of Dental 3D Printing Market Study

  • Recent trend of customisation of dental prosthetics is ensuring better fitting of implants with minimal wastage of materials in a stipulated time, which is projected to intensify demand for dental 3D printing technology.
  • Incorporation of advanced technologies for the development of dental 3D printers is turning highly cost-intensive, which could limit the penetration of these devices in price-sensitive regions such as the Middle East and Africa.
  • Continuous evolution of additive manufacturing technology entails a rapid change in the operation of dental 3D printers and their software. Lack of proper training to use such devices could limit adoption opportunities for players in the dental 3D printing market.
  • Investments from both-public and private sectors-would remain crucial to underpin research & development activities undertaken by players in the dental 3D printing market, to introduce novel technologies in the U.S. and China. Besides this, the Chinese government is braced up to prepare the future workforce by introducing concepts of 3D printing technologies in educational courses.

 Report Methodology- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4361

Numerous Strategies of Manufacturers Narrowing Down to One Intention – Product Innovation

The consolidated dental 3D printing market offers low entry-level barriers to new entrants, which is increasing the threat of new players, especially the ones that are well-established manufacturers of 2D printers and hold a robust distribution network. However, the dominance of Stratasys Ltd., 3D Systems, Inc., Concept Laser GmbH, and EnvisionTEC Inc. will remain high, with a collective share of nearly 50% during the forecast period.

Leading players adopt numerous strategies with an intent to boost the exclusiveness of their products. For example, Stratasys Ltd., through its in-house expertise, introduced the Stratasys J700 Dental 3D Printing Solution, which is the fastest PolyJet technology-based dental 3D printer used for the production of clear aligner moulds. Another player-3D Systems Ltd.-approaches product breakthrough with the help of collaborations. 3D Systems Ltd. announced the acquisition of Vertex Global Holding B.V., a key provider of dental materials. The acquisition is intended to integrate 3D Systems’ technology with the company’s materials to further advance the extant scope of dental 3D printing technology.

Buy Now  https://www.factmr.com/checkout/4361

Find More Valuable Insights on Dental 3D Printing Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global dental 3D printing market, presenting historical demand data (2017-2019), and forecast statistics for the period of 2020-2027. The study divulges compelling insights on the dental 3D printing market on the basis of application (dental implants, crowns & bridges, dentures, and others), material (metals, ceramics, photopolymers, and others), and technology (vat photo polymerization, fused deposition modelling, PolyJet technology, selective laser sintering, and others), across five major regions.

For More Insights- https://www.biospace.com/article/rising-demand-for-minimally-invasive-surgeries-will-drive-surgical-imaging-robots-market-fact-mr-study/

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Gonorrhea Therapeutics Is Set To Witness Exponential Growth In Demand Over The Coming Years

According to a new study of Fact.MR, the gonorrhea therapeutics market will reach ~US$ 970 Mn in 2019, and estimated to register a 4% Y-o-Y over 2018. The gonorrhea therapeutics industry will remain influenced by increased attention on new developments in novel therapeutic compounds or antimicrobials for improving the success potential of future treatment.

There has been a significant rise in the prevalence of gonorrhea that is resistant to components of dual antibiotic therapy – ceftriaxone and azithromycin, which is the only recommended treatment for gonorrhea. In addition, resistance to several other antibiotics apart from dual antibiotic therapy resulted in ‘super gonorrhea’, which has become a buzzword in the gonorrhea therapeutics market. With a slew of promising new antibiotics on the horizon, alongside surveillance, education and preventative measures to stymie prevalence of super-resistant gonorrhea, prospects seem bullish for the gonorrhea therapeutics market.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=3761

Dual Therapy Remains the Treatment of Choice

The market of gonorrhea therapeutics is likely to grow in parallel with the potentially effective drugs that are currently in pipeline. Growing number of clinical trials and rising investments in healthcare industry will continue to pave lucrative avenues of growth for the gonorrhea therapeutics market. The study opines that dual therapy will remain the treatment of choice for gonorrhea, accounting for ~90% market shares. This falls in line with the current recommended regimen for gonorrhea treatment that includes a combination of two antibiotics, azithromycin, which is given orally, and ceftriaxone, an intra-muscular drug.

For critical insights on this market, request for methodology here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=3761

According to the study, azithromycin will continue to account for greater gains in the gonorrhea treatment market, closely trailed by the third-generation cephalosporin that are increasing gaining traction. Azithromycin sales for the treatment of gonorrhea are expected to hold ~50% market shares. Sales of third-generation cephalosporin are expected to grow at a rate similar to that of azithromycin in the foreseeable future. As some countries turn to increasing the doses of the recommended gonorrhea drugs in an attempt to overcome the bacteria’s resistance, the demand for macrolide antibiotics and third-generation cephalosporin is likely to grow steadily in coming years.

According to the Fact.MR study, lucrativeness of developed markets – North America and Europe – for gonorrhea therapeutics will endure, primarily underpinned by growing prevalence of STDs and rapidly advancing healthcare infrastructure in these regions. In the US alone, ~1 Mn cases of gonorrhea are reported annually, according to recent studies. Favorable reimbursement policies and government funding to numerous health organizations for the development of drug-resistant gonorrhea treatment will remain the key growth influencers of the market in these regions.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/3761

The study further opines that companies in gonorrhea therapeutics market are making bulk investments in building a robust pipeline, while focusing on drug approvals in different regions. However, the overall reluctance of gonorrhea drug manufacturing in line with long regulatory processes and complications associated with eventual antibiotic resistance of drugs could team up against the steady growth of gonorrhea therapeutics market.

For More Insights- https://www.einpresswire.com/article/556694532/how-has-covid-19-impacted-the-surgical-drapes-industry-fact-mr-s-post-pandemic-analysis

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand For Dyslipidemia Therapeutics Market Is Set To Grow At A Higher Pace Over The Medium- And Long-Run Forecast Period 2022- 2032

According to Fact MR’s recent market research, Dyslipidemia Therapeutics sales to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Dyslipidemia Therapeutics market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

 Request Sample –   https://www.factmr.com/connectus/sample?flag=S&rep_id=2928

Digital Transformation in Healthcare Presenting Opportunities for Dyslipidemia Therapeutics Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Dyslipidemia Therapeutics market.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Dyslipidemia Therapeutics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Dyslipidemia Therapeutics

The report offers actionable and valuable market insights of Dyslipidemia Therapeutics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Dyslipidemia Therapeutics Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Dyslipidemia Therapeutics, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Dyslipidemia Therapeutics Market.

According to a recently released Fact.MR study, revenues from dyslipidemia therapeutics market surpassed US$ 36 billion in 2018. Low-density lipoproteins held approximately two-thirds of revenues from dyslipidemia therapeutics worldwide in 2018. As high LDL levels have been associated with increased risks of heart attacks, strokes, and other cardiovascular problems in humans, governments around the world are launching various campaigns to raise awareness about the adverse impact of high LDL levels in the blood.

The growing prevalence of cardiovascular disorders worldwide has prompted individuals to effectively manage their LDL levels. To capitalize on the current trends prevalent in the dyslipidemia therapeutics market, pharmaceutical companies continue to strive towards developing new and improved therapies to lower LDL levels, and effectively manage the percentage of other lipids in the blood. A range of new treatments such as combination therapies, gene editing, and novel target drugs are under development, particularly for dyslipidemia therapeutics.

Statins Persist as Preferred Drug Class for Dyslipidemia Therapeutics

Fact.MR estimates the sales of statins for dyslipidemia therapeutics to exceed $20,000 million in 2019. Statins continue to remain the first line of drugs prescribed by doctors to manage and treat dyslipidemia. Statin drugs are deemed useful in reducing LDL levels in humans, with their effectiveness in lowering LDL level being approximately 60%.

 Report Methodology-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=2928

Clinical trials commend statin drugs to substantially reduce the risk of cardiovascular diseases, while stabilizing the blood vessels lining and reducing inflammation. Its ability to aid in blood vessel relaxation also contributes to lowering blood pressure in patients.  Moreover, the growing prevalence of chemoprophylaxis, caused by consumption of statins is further expected to bolster demand for dyslipidemia therapeutics as a consequence.

Gains from other drugs for dyslipidemia therapeutics are expected to remain gradual, with demand arrested by concerns regarding side-effects of statins. There has been a notable rise in the development of alternative drugs, owing to certain health impacts associated with the consumption of statins including muscular pain, the onset of type 1 diabetes, and hemorrhagic stroke.

Non-statins and PCSK9 have witnessed widespread acceptance as an alternative to statins in dyslipidemia therapeutics. Furthermore, with research towards the use of nutraceuticals in clinical practices for dyslipidemia treatment intensifying, pharmaceutical companies are expected to witness significant opportunities in the functional food space.

North America Remains Lucrative for Dyslipidemia Therapeutics Market

The high consumption of fast food and stressful lifestyle of the North American population is one of the key reasons behind the growing incidences heart diseases in the continent. According to a report released by the Centers for Disease Control and Prevention (CDC) cardiovascular diseases were found to be the top cause of deaths in the United States of America in 2017. Another report from the CDC suggested a total of 48.6% US adults were eligible for statin therapy signifying the high prevalence of dyslipidemia in the country. Consequently, the sales of dyslipidemia therapeutic drugs are likely to stay high and the Fact.MR study estimates that the dyslipidemia therapeutics market will witness a growth of 2.9% through 2019.

Apart from North America, China presents lucrative opportunities for the dyslipidemia therapeutics market where the condition was identified as the key cause behind increasing incidences of cardiovascular diseases in the country. Following the discovery, the China Clinical Control of Dyslipidemia (CCCD) has been continuously releasing guidelines to reduce the condition in the country. These factors are likely to aid in the progression of the dyslipidemia therapeutics market in the country.

Dyslipidemia Therapeutics Market – Segmentation

The dyslipidemia therapeutics market report offers a detailed analysis of the dyslipidemia market on the basis of different segments. A comprehensive analysis of each of the dyslipidemia therapeutics market segments on the basis of value, Y-o-Y growth, revenue share, and CAGR has been provided in the report.

The dyslipidemia therapeutics market has been segmented on the basis of drug class, distribution channel, type, and region.

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/2928

Report Benefits & Key Questions Answered

  • Dyslipidemia Therapeutics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Dyslipidemia Therapeutics Historical volume analysis: The report provides a comparison of Dyslipidemia Therapeutics’s historical sales and projected sales performance for 2021-2031.
  • Dyslipidemia Therapeutics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Dyslipidemia Therapeutics market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Dyslipidemia Therapeutics Consumption by demographics: The report investigates consumer behavior affecting Dyslipidemia Therapeutics demand outlook for the assessment period. Effect of their keenness for digital trends on Dyslipidemia Therapeutics market is carefully analyzed
  • Post COVID consumer spending on Dyslipidemia Therapeutics: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Dyslipidemia Therapeutics market growth.

For More Insights-  https://www.einpresswire.com/article/556865366/higher-demand-for-renewable-products-will-increase-the-market-for-bio-based-propylene-glycol-over-the-forecast-period

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand For Atopic Dermatitis Market Is Poised To Surpass A Valuation Of US$ 19 Bn By The End Of The Forecast Period 2022-2032

The research report published by Fact.MR on the Survey of Atopic Dermatitis Market is intended to offer reliable data on various key factors shaping the growth curve & outlook of Atopic Dermatitis market. This report works as a rich source of information for key entities such as policy makers, end-use industries, investors, and opinion leaders. The Demand analysis of Atopic Dermatitis Market offers a comprehensive analysis of diverse features, demand, product developments, revenue generation, and sales of Atopic Dermatitis Market across the globe.

Click Here To get a Sample Report :-https://www.factmr.com/connectus/sample?flag=S&rep_id=4603

Global Atopic Dermatitis Drugs Market Segmentation

Fact.MR has studied the global atopic dermatitis drugs market with detailed segmentation on the basis product type, application and key regions.

Drug Class
  • Corticosteroids
  • PDE4 Inhibitors
  • Biologics
  • Skin Barrier Emollients
  • CNI Immunosuppressants
  • Others
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Key Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

The Market survey of Atopic Dermatitis offers a comprehensive analysis of diverse features, including production capacities analysis of Atopic Dermatitis, demand, product developments, revenue generation, and Size of Atopic Dermatitis Market across the globe.

Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4603

Some Notable Offerings by Fact.MR Report on Atopic Dermatitis market:

  • We will provide you an analysis of the extent to which this Atopic Dermatitis market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
  • We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
  • Also, this report will help you to identify any trends to forecast growth rates.
  • The analyzed report will forecast the general tendency for supply and demand.

Some of the Atopic Dermatitis Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides: 

  • Details regarding latest innovations and development in Atopic Dermatitis and how it is gaining customer traction during the forecast period.
  • Analysis about the customer demand of the products and how it is likely to evolve in coming years.
  • Latest regulations enforced by government bodies and local agencies and their impact on Demand of Atopic Dermatitis Market .
  • Insights about adoption of new technologies and its influence on the Atopic Dermatitis market Size.
  • Overview of the impact of COVID-19 on Atopic Dermatitis Market and economic disruptions caused by the pandemic.
  • Evaluates post-pandemic impact on the Sales of Atopic Dermatitis Market during the forecast period.

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=4603

After reading the Market insights of Atopic Dermatitis Report, readers can:

  • Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
  • Analyze key regions holding significant share of total Atopic Dermatitis market revenue.
  • Study the growth outlook of Atopic Dermatitis market scenario, including production, consumption, history and forecast.
  • Learn consumption pattern and impact of each end use & supply side analysis of Atopic Dermatitis market.
  • Investigate the recent R&D projects performed by each market player & competitive analysis of Atopic Dermatitis Market Players.

To get all-in insights on the regional landscape of the Atopic Dermatitis Market, buy now:-https://www.factmr.com/checkout/4603

How Fact.MR Assists in Making Strategic Moves For Atopic Dermatitis Market Manufacturer?

  • The data provided in the Atopic Dermatitis market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
  • The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

For More Insight- https://www.biospace.com/article/demand-for-fusion-protein-biosimilars-is-increasing-for-the-treatment-of-cancer-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Patient Positioning Market Gain Impetus Due To The Growing Demand By Rising Prevalence Of Chronic Diseases – Fact.MR Study

In 2020 the global patient positioning system market was valued at US$ 1 Bn and is expected to increase by nearly US$ 500 Mn by the end of 2031. Fact.MR, market research and competitive intelligence provider has also predicted the global patient positioning system industry to progress at a modest CAGR of 4.5% over the forecast period.

Market CAGR (2021-2031) 4.5%
Global Market Value by 2031 US$ 1.5 Bn
Market Value in 2020 US$ 1 Bn
North America Market Share 40%

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=52

Digital Transformation in Healthcare Presenting Opportunities for Patient Positioning Systems Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Patient Positioning Systems market.

Patient positioning system market regional analysis by Fact.MR

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=52

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Patient Positioning Systems market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Patient Positioning Systems

The report offers actionable and valuable market insights of Patient Positioning Systems. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Patient Positioning Systems Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Patient Positioning Systems, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Patient Positioning Systems Market.

Market Snapshot

In 2020 the global patient positioning system market was valued at US$ 1 Bn and is expected to increase by nearly US$ 500 Mn by the end of 2031. Fact.MR, market research and competitive intelligence provider has also predicted the global patient positioning system industry to progress at a modest CAGR of 4.5% over the forecast period.

Market CAGR (2021-2031) 4.5%
Global Market Value by 2031 US$ 1.5 Bn
Market Value in 2020 US$ 1 Bn
North America Market Share 40%

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/52

Key Segments of Patient Positioning System Industry Survey

·         By Product:

    • Patient Positioning Tables
    • Surgical Tables
    • Radiolucent Imaging Tables
    • Examination Tables
    • Patient Positioning Accessories
    • Other Patient Positioning Systems

·         By End User:

    • Hospitals
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Others

·         By Application:

    • Use of Patient Positioning Equipment in Surgery
    • Demand for Patient Positioning Systems for Diagnostics & Imaging
    • Demand for Patient Positioning for Cancer Therapy
    • Others

Competitive Landscape

Increasing research and investments by manufacturers of patient positioning systems and rising demand for improving healthcare infrastructure across the world are expected to strengthen market growth potential.

  • A leading name in biomedical vertical from Italy, Esaote announced its entry in the total body MRI industry with the launch of a system – Magnifico Open. The new launch is aimed at providing comfortable and efficient patient positioning, especially for claustrophobic and younger individuals.
  • In July 2021, A J Hospital & Research in Mangaluru, Karnataka, India, announced the installation of one of the most modern CT systems. The 128 Slice Dual Energy CT scanner is equipped with AI to optimise patient positioning and offering better assistance to technologists.

Boron’s neutron capture therapy (BNCT) treatment room at the Helsinki University Hospital is being developed to realize its full clinical potential by partnering with various industry leaders. The room will be equipped with state-of-the-art robotic patient-positioning systems.

The need for patient positioning systems is anticipated to be driven by rising geriatric population and increasing demand for elderly care services. Patient positioning systems aid in repositioning patients and provide mobility for those recovering from surgeries or injuries. These systems also assist surgeons in ensuring patient safety and ease of access for doctors performing surgeries.

Rise in number of surgeries performed, increasing prevalence of chronic diseases that require hospitalization and professional care, technological advancements to facilitate and make procedures easy, and increasing demand for therapies are some of the major factors propelling demand for patient positioning systems.

Fierce competition among manufacturers is a major factor that is anticipated to have a restraining effect on market growth since this has spawned many substitute technologies. Untapped potential from lesser developed economies and economies with rising healthcare expenditure are expected to be prominent and crucial to overall market growth.

Key Takeaways from Market Study

  • Patient positioning system market to expand at a steady CAGR of 4.5% through 2031.
  • In 2020, the market reached a valuation of around US$ 1 Bn.
  • North America anticipated to account for nearly 40% of global market share.
  • China and India markets expected to grow at high CAGRs in APAC region.
  • Sales revenue from patient positioning systems anticipated to be around US$ 1.5 Bn by the end of 2031.

“Increasing prevalence of chronic diseases has led to a rise in surgical and therapeutic procedures, which is expected to drive demand for patient positioning systems,” says a Fact.MR analyst.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Patient Positioning Systems Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Patient Positioning Systems Historical volume analysis: The report provides a comparison of Patient Positioning Systems’s historical sales and projected sales performance for 2021-2031.
  • Patient Positioning Systems Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Patient Positioning Systems market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Patient Positioning Systems Consumption by demographics: The report investigates consumer behavior affecting Patient Positioning Systems demand outlook for the assessment period. Effect of their keenness for digital trends on Patient Positioning Systems market is carefully analyzed
  • Post COVID consumer spending on Patient Positioning Systems: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Patient Positioning Systems market growth.

More Valuable Insights on Patient Positioning Systems Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Patient Positioning Systems, Sales and Demand of Patient Positioning Systems, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

 

Categories
Pharmaceutical

Demand for Drug Eluting Balloon Catheter Increasing with Rising Cases of Cardiovascular Disease – Fact.MR Study

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Drug Eluting Nylon Balloon Catheter market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Drug Eluting Nylon Balloon Catheter

The report offers actionable and valuable market insights of Drug Eluting Nylon Balloon Catheter. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Drug Eluting Nylon Balloon Catheter Market across various industries and regions.

To remain ‘ahead’ of your competitors, request for a sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=146

This newly published and insightful report sheds light on Market Insights of Drug Eluting Nylon Balloon Catheter, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Drug Eluting Nylon Balloon Catheter Market.

The scope of Fact.MR’s report is to analyze the global drug-eluting balloon catheter market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global drug-eluting balloon catheter market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to medical devices.

Drug eluting balloon catheter market regional analysis by Fact.MR

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=146

Market Snapshot

The global market for drug eluting balloon catheters is anticipated to progress at an impressive CAGR of 18% over the next ten years. This analysis has been performed by skilled analysts at Fact.MR, a market research and competitive intelligence provider, also reveals that demand for drug eluting balloon catheters comprises 20% share in the overall balloon catheters market at present. As per the study, the global drug eluting balloon catheter market is expected to be worth US$ 5.2 Bn by the end of 2031, with coronary artery disease drug eluting balloon catherization holding a mammoth 80% market share.

Global Market Value in 2021 US$ 1 Bn
CAGR (2021-2031) 18%
Forecasted Market Value for 2031 US$ 5.2 Bn
Dominant Market Europe

MaKey Segments of Drug Eluting Balloon Catheter Industry Surveyrket Taxonomy

·         By Indication:

    • Coronary Artery Disease Drug Eluting Balloon Catheters
    • Peripheral Vascular Disease Drug Eluting Balloon Catheters

·         By End User:

    • Hospitals
    • Ambulatory Surgical Centers
    • Cardiac Catheterization Laboratories

·         By Raw Material:

    • Polyurethane Drug Eluting Balloon Catheters
    • Nylon Drug Eluting Balloon Catheters
    • Others

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/146

Competitive Landscape

Research in the drug eluting balloon catheter space by key players is anticipated bolster development and sales of more precise and efficient drug eluting balloon catheters.

  • In February 2021, L2Mtech GmbH was awarded its first CE mark on six products. This marks a milestone in the company’s history and proves the efficacy and safety of its innovative cardiovascular and endovascular applications. The company is planning to commercially launch the products with the CE mark recognition.
  • In June 2020, iVascular SLU, a medical device company, announced the global launch of its novel coronary artery drug-coated balloon. The product – Essential Pro – has several improvements from its predecessor.
  • In March 2021, MedAlliance announced that it had received FDA approval for its drug-eluting coronary balloon. The product is called the Selution SLR sustained limus release drug-eluting balloon catheter. It received a go-ahead for its design, which improved luminal diameter in individuals affected with atherosclerotic lesions.

Increasing prevalence of cardiovascular diseases has created massive demand for related treatments. Cardiology intervention procedures have grown in popularity as well as their effectiveness has substantially been accepted across the globe. Focus on healthcare is more prominent than ever before due to the shortcomings that were noticed amidst the COVID-19 pandemic. Favorable reimbursement policies by health insurance providers and rising geriatric population are also factors that are set to propel demand for drug eluting balloon catheters.

However, risk of infection through the collapse of balloon catheters is expected to restrain market growth to some extent. This is being addressed as next-generation drug eluting balloon catheters are being researched and launched.

Key Takeaways from Market Study

  • Drug eluting balloon catheter market expected to be worth US$ 5.2 Bn by 2031.
  • Demand is anticipated to increase at impressive CAGR of 18%.
  • Europe estimated to dominate global market in terms of market share.
  • High cost and risk of infections expected to hinder demand for drug eluting balloon catheters.
  • U.K market is anticipated to rise at astronomical CAGR of around 20% over next ten years.
  • Surging instances of cardiovascular diseases, rising geriatric population, and attractive reimbursement policies by healthcare insurance providers are major factors driving sales.

“Increasing research & development by drug eluting balloon catheter manufacturers is anticipated to favor the industry in terms of demand and sales,” says a Fact.MR analyst.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Key Question answered in the survey of Drug Eluting Nylon Balloon Catheter market report:

  • Sales and Demand of Drug Eluting Nylon Balloon Catheter
  • Growth of Drug Eluting Nylon Balloon Catheter Market
  • Market Analysis of Drug Eluting Nylon Balloon Catheter
  • Market Insights of Drug Eluting Nylon Balloon Catheter
  • Key Drivers Impacting the Drug Eluting Nylon Balloon Catheter market
  • Which are the Key drivers impacted by Drug Eluting Nylon Balloon Catheter market
  • Restraints Shaping Market Growth
  • Market Survey of Drug Eluting Nylon Balloon Catheter

More Valuable Insights on Drug Eluting Nylon Balloon Catheter Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Drug Eluting Nylon Balloon Catheter, Sales and Demand of Drug Eluting Nylon Balloon Catheter, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Antimicrobial Susceptibility Test Market to Register 6.5% CAGR Amid Burgeoning Incidence of Antibiotic Resistance – Fact.MR Study

Recent times have witnessed a marked shift towards personalised medicines, which is increasing the demand for antimicrobial susceptibility testing products.

Rising government initiatives regarding the development of quality hospital infrastructure, on a global level, and surging susceptibility to infectious diseases, are projected to complement the demand for antimicrobial susceptibility tests in diagnostic laboratories and hospitals during the forecast period (2020-2025).

Besides these institutes, antimicrobial susceptibility test kits are gaining traction in the pharmaceutical and biotechnology sectors for the research & development of new drugs to fight bacteria. In the future, online sales channels will remain a crucial propeller to the growth of the antimicrobial susceptibility test market, as market players intend to penetrate local markets.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=4334

Diagnostic laboratories and hospitals are projected to remain crucial end users, and a substantial chunk of product sales will close from the clinical diagnosis of bacteria, fungi, and parasites. Given the impact of numerous dynamics recorded in an exclusive study published by Fact.MR, the antimicrobial susceptibility test market is projected to record year-over-year growth of 6.5% in 2020, over 2019.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Antimicrobial Susceptibility Test market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Antimicrobial Susceptibility Test

top segments focus on in antimicrobial susceptibility test market

The report offers actionable and valuable market insights of Antimicrobial Susceptibility Test. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Antimicrobial Susceptibility Test Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Antimicrobial Susceptibility Test, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Antimicrobial Susceptibility Test Market.

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=4334 

Antimicrobial Susceptibility Test Market – Assessment of Key Segments

Authors of the report have segmented the antimicrobial susceptibility test market into key categories in order to study the market at a microscopic level. The key segments considered while bifurcating the antimicrobial susceptibility test market include:

Product
  • Kits, Reagents, & Consumables
  • Automated Test Systems
  • Culture Media
Method
  • Broth Dilution Method
  • Rapid Automated Method
  • Disk Diffusion Method
  • Gradient Diffusion Method
  • Molecular Testing Method
Test Type
  • Antibacterial
  • Antiparasitic
  • Antifungal
  • Others
Application
  • Clinical Diagnosis
  • Drug Discovery and Development
  • Others
End User
  • Diagnostic Laboratories and Hospitals
  • Research and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Besides laying focus on the aforementioned key segments, the report also studies the antimicrobial susceptibility test market at a country level, to recalibrate the underlying opportunities available for players in the antimicrobial susceptibility test market for the forecast period.

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4334

Online Sales Channel – Winning Strategy

The online purchase of antimicrobial susceptibility test kits is projected to evolve as a significant trend during the forecast period of 2020-2025. This is encouraging numerous vendors to improve their online brand recognition value through effective marketing efforts and promotional strategies.

The emergence of these channels will also translate into reduced costs, which are otherwise incurred by brick-and-mortar distribution centres for maintenance purposes. In addition, this is expected to prove beneficial for players to increase their exposure in the antimicrobial susceptibility test market.

Key Highlights of Antimicrobial Susceptibility Test Market Study

  • Ease of sample processing through the use of advanced lab instruments and better turnaround time of samples are projected to create a large patient pool for diagnosis, which, in turn, will amplify the demand for antimicrobial susceptibility test kits during the forecast period.
  • Online sales channels are emerging as an integral revenue stream for the antimicrobial susceptibility test market. These channels are being leveraged by key vendors to disseminate brand information and gain access to local markets.
  • Initiatives taken by central health authorities are projected to draw consumers’ attention towards the importance of antibiotics. For instance, WHO observes a week in November as World Antibiotic Awareness Week (WAAW), to inspire the best clinical practices among health workers and policymakers in order to control antibiotic resistance.
  • Introduction of advanced antimicrobial susceptibility tests, which offer results in around 2 hours, sets the standards for better patient outcomes. For instance, FASTinov announced the launch of a rapid antimicrobial susceptibility test, which is based on flow cytometry, to offer clinically-implementable results in as little as two hours. Such advancements are likely to inspire the development of effective test products.

A senior market research analyst at Fact.MR opines that– “An entry into the antimicrobial susceptibility test market is highly capital-intensive, as CAPEX includes the cost of sophisticated equipment and skilled labor. In addition, capital becomes an essential fuel to foster R&D activities, which could create an entry barrier for new players in the antimicrobial susceptibility test market.”

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Antimicrobial Susceptibility Test Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Antimicrobial Susceptibility Test Historical volume analysis: The report provides a comparison of Antimicrobial Susceptibility Test’s historical sales and projected sales performance for 2021-2031.
  • Antimicrobial Susceptibility Test Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Antimicrobial Susceptibility Test market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Antimicrobial Susceptibility Test Consumption by demographics: The report investigates consumer behavior affecting Antimicrobial Susceptibility Test demand outlook for the assessment period. Effect of their keenness for digital trends on Antimicrobial Susceptibility Test market is carefully analyzed
  • Post COVID consumer spending on Antimicrobial Susceptibility Test: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Antimicrobial Susceptibility Test market growth.

More Valuable Insights on Antimicrobial Susceptibility Test Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Antimicrobial Susceptibility Test, Sales and Demand of Antimicrobial Susceptibility Test, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

 

Categories
Pharmaceutical

Hormone Replacement Therapy Market to Register 6% CAGR Driven by Growing Prevalence of Diabetes Worldwide – Fact.MR Study

The hormone replacement therapy market is a fragmented landscape with presence of few tier one companies and upcoming players.

Top five companies involved in the hormone replacement therapy formulations account for a significant share of the overall hormone replacement therapy market.

Top 5 players – Novo Nordisk, Pfizer Inc., Janssen NV (a Johnson & Johnson company), Novartis AG and Bayer AG collectively – collectively account for 35 percent revenue share of the hormone replacement therapy market from on the global front.

Tier 1 hormone replacement therapy companies are focused on carrying out clinical trials for new product development (NPD). Moreover, these companies are adopting vertical, horizontal and backward integration in a bid to achieve rapid expansion and pace in technological development.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=2224

The hormone replacement therapy market is foreseen to expand at a significant pace with sales of hormone replacement therapy products crossing US$ 12,000 Mn by 2019 end.

Rising incidences of osteoporosis fractures coupled with growing menopause rates among women have remained instrumental in driving the demand for hormone replacement therapy. Fact.MR envisages that the demand for hormone replacement therapy is projected to expand at a CAGR of 6.0% in terms of value throughout the period of forecast, 2018-2028.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Hormone Replacement Therapy market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Hormone Replacement Therapy

Hormone replacement therapy market 1

The report offers actionable and valuable market insights of Hormone Replacement Therapy. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Hormone Replacement Therapy Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Hormone Replacement Therapy, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Hormone Replacement Therapy Market.

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=2224

Market Structure

The hormone replacement therapy market is segmented in detail to cover every angle of the hormone replacement therapy space.

The hormone replacement therapy market has been segmented on the basis of product type, by dosage form, by indication, by distribution channel and by region.

Various hormone replacement therapy products such as estrogen hormone replacement therapy, thyroid hormone replacement therapy and growth hormone replacement therapy is covered.

By dosage form, hormone replacement therapy market is segmented into tablets, patches, injections, implants and creams.

By indications, hormone replacement therapy market is categorized into menopause, osteoporosis, thyroid and growth hormone deficiency.

By distribution channel, it is segmented by hospital pharmacies, clinics, retail pharmacies and online pharmacies.

The hormone replacement therapy market is assessed across key regions such as North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Middle East and Africa (MEA) and Japan.

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/2224

Competitive Landscape

The report on hormone replacement therapy market offers intelligence on key participants in the hormone replacement therapy market.

The key companies involved in the formulation of hormone replacement therapy products are thoroughly assessed and profiled in the report.

Various facets of competition including SWOT analysis, product portfolio analysis, drug developments and innovations, strategies and key financials are covered. Key companies profiled in the report include

  • Novartis AG
  • Novo Nordisk A/S
  • Teva Pharmaceuticals
  • Mylan N.V and Pfizer Inc.

Stakeholders in the hormone replacement therapy can find attractive opportunities in developed countries in North America, particularly the United States. According to the American Congress of Obstetricians and Gynecologists, around 6,000 women reach menopause every day, reaching a count of over 2 million annually. This has translated into significant adoption of hormone replacement therapy in the country. The demand for hormone replacement therapy in the US is also accompanied by higher GDP per capita, triggering high healthcare expenditure.

The report also foresees that the hormone replacement therapy market in Asia Pacific excluding Japan (APEJ) region is poised to expand at a relatively higher pace as compared to other regions. According to the report, the APEJ hormone replacement therapy market is projected to expand at a stellar pace of 7.2% during the assessment period. This growth can be attributed to increasing population coupled with higher life expectancy in emerging economies such as India and China. Against this backdrop, stakeholders in hormone replacement therapy market can expect optimistic growth in the region in the years to follow, leveraging its lucrativeness from an investment standpoint.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Hormone Replacement Therapy Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Hormone Replacement Therapy Historical volume analysis: The report provides a comparison of Hormone Replacement Therapy’s historical sales and projected sales performance for 2021-2031.
  • Hormone Replacement Therapy Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Hormone Replacement Therapy market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Hormone Replacement Therapy Consumption by demographics: The report investigates consumer behavior affecting Hormone Replacement Therapy demand outlook for the assessment period. Effect of their keenness for digital trends on Hormone Replacement Therapy market is carefully analyzed
  • Post COVID consumer spending on Hormone Replacement Therapy: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Hormone Replacement Therapy market growth.

More Valuable Insights on Hormone Replacement Therapy Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Hormone Replacement Therapy, Sales and Demand of Hormone Replacement Therapy, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Citicoline Market to Surpass US$ 500 Mn In Response to Rising Incidence of Alzheimer’s Disease and Glaucoma in Geriatric Population – Fact.MR Study

According to Fact MR’s recent market research, sales of Citicoline to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Citicoline market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=2868

According to a recent research by Fact.MR, the citicoline market is estimated to surpass US$ 550 million in 2019. Citicoline demand is driven by a range of factors, notably increasing geriatric population and growing use among eSports players. The study offers in-depth and incisive insights on key factors influencing the global demand for citicoline.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Citicoline market.

citicoline market snapshot

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Citicoline market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Citicoline

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=2868

Citicoline Market – Competitive Landscape

  • In order to capitalize on the growing demand for citicoline in functional foods, Kyowa Hakko Bio Co., Ltd., a leading player in the citicoline market, launched two new citicoline powdered supplements and citicoline capsules in 2018.
  • Intensifying clinical trials for citicoline’s potential use in the treatment of neurological diseases received a substantial boost after research suggested that using the compound with risperidone could effectively relieve primary negative symptoms of schizophrenia.
  • The pervasive trend of combining citicoline with other compounds to enhance its efficacy continues to drive the citicoline market growth with a study published in 2018 concluding that a combination of citicoline and docosahexaenoic acid exhibit synergistic activities which can substantially boost recovery after transient brain ischemia.

Some of the leading players operating in the citicoline market include Alfa Aesar, Cepham, Inc., EZ Melts, HL-Pharma US, Double Wood LLC, Instas Pharmaceuticals Ltd., Jarrow Formulas, Inc., Kimia Biosciences, Rakshit Drugs Pvt., Ltd., Relentless Improvement LLC, Swanson, Wellona Pharma Private Limited, Healthy Origins, Biochemix Healthcare Pvt., Ltd., Merck KGaA, Grupo Ferrer Internacional, S.A., Piping Rock Health Products, LLC, and NuerAxon Pharma Inc.

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/2868

Supplement Consumption Among eSports Players: A Lucrative Opportunity

Growing popularity and increasing investments in electronic Sports is helping the market go mainstream which, in turn, is opening an assortment of opportunities for various industries. Players participating in eSports tournaments are seeking cognitive enhancing supplements which can help them concentrate, plot strategies, and improve working memory. Additionally, a ban on the use of other nootropics such as Ritalin and Adderall in eSports leagues is creating demand for ‘permissible’ supplements. Citicoline’s negligible toxicity and its organic nature is making it an appealing prospect for eSports players. With regulations allowing the use of citicoline in functional food and supplements, manufacturers are increasingly focusing towards including the compound in their products to capitalize on the bolstering demand for cognitive-enhancing supplements in eSports.

Citicoline’s Role in Ischemic Stroke Treatment Creating Opportunities

The adverse and often fatal impact of ischemic stroke on human health, coupled with increasing prevalence is bolstering demand for effective treatment of the condition. According to WHO, stroke is the second leading cause of death in the world and the third leading cause of disabilities in adults. Additionally, the lack of a standard procedure of treatment for different ischemic stroke patients is influencing healthcare researchers to focus on the development of acute therapy for all patients. According to Fact.MR’s study, citicoline is being viewed as a potential treatment option by researchers and healthcare providers. These factors are vital to citicoline market growth and are expected propel proliferation during the forecast period.

The study opines that citicoline demand is also likely to be influenced by its role in treatment of brain injuries. Studies suggest treatment of patients with citicoline has been beneficial in reducing headaches, dizziness, tinnitus, and in substantially relieving motor, cognitive, and mental symptoms. These developments are further driving researchers towards testing its potential use in treatment for pervasive developmental disorders such as atypical autism, Asperger Syndrome, and autism. Intensifying clinical trials and research and developmental activities in the area are expected to open new and lucrative opportunities for companies in the citicoline market.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Citicoline Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Citicoline Historical volume analysis: The report provides a comparison of Citicoline’s historical sales and projected sales performance for 2021-2031.
  • Citicoline Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Citicoline market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Citicoline Consumption by demographics: The report investigates consumer behavior affecting Citicoline demand outlook for the assessment period. Effect of their keenness for digital trends on Citicoline market is carefully analyzed
  • Post COVID consumer spending on Citicoline: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Citicoline market growth.

More Valuable Insights on Citicoline Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Citicoline, Sales and Demand of Citicoline, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates